Quadriga BioSciences has concluded patient enrolment in a Phase I clinical trial of QBS10072S (QBS72S) to treat advanced or metastatic solid cancers.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,